# Zhejiang Huahai Pharmaceutical Co., Ltd. – FDA Inspection, Nov 18, 2016

Source: https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/0b357083-d8c1-4b5b-9169-ab1f1c610575
Source feed: FDA_Inspections

> FDA inspection 993041 of Zhejiang Huahai Pharmaceutical Co., Ltd., November 18, 2016. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 993041
- Company Name: Zhejiang Huahai Pharmaceutical Co., Ltd.
- Inspection Date: 2016-11-18
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1319736 - 2026-04-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/63e5b9f3-f398-4916-8957-fca50802a442)
- [FDA Inspection 1259818 - 2025-01-24](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/6c8aed33-ef33-4a48-97c2-992934935373)
- FDA Inspection 1149252 - 2021-07-02
- [FDA Inspection 1094941 - 2019-06-28](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/df4d4247-aa87-49a8-a139-e03b3c32f929)
- [FDA Inspection 1093250 - 2019-05-31](https://www.keypedia.com/records/fda_inspections/zhejiang-huahai-pharmaceutical-co-ltd/2b5b7233-044f-42f2-ac3f-00e6696bfc49)

## Related Officers

- [Investigator](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)
- [FDA Associated Person](https://www.keypedia.com/people/peter-e-baker/c32eb848-de28-4725-80c9-ef8548d445bf)

Company: https://www.keypedia.com/companies/zhejiang-huahai-pharmaceutical-co-ltd/77f8f66f-ca2e-4b91-b460-a4bd2041c866

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c